Urology Cancer Summit
The First International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Related Articles
Urology Cancer Summit
The First International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data – PubMed
Prostate cancer treatments can cause long-term urinary adverse events (UAEs), but time-varying risks across treatments remain understudied. Using Surveillance, Epidemiology and End Results-Medicare data, we…
Urology Cancer Summit – registration
The International Urology Cancer Summit is a free and independent educational opportunity open to everyone involved in caring for patients with urologic cancers.
Home – ClinicalTrials.gov
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. ClinicalTrials.gov is a registry and results database of…
ASCO Day 4: The Birmingham Screwdriver | Richard Simcock
The Birmingham Screwdriver, chemo before lunch and the joy of sex. My final round-up from ASCO. Thanks for everyone who said hello and for all…
ASCO 2025: FGFR3 Alteration Status and Outcomes with Immune Checkpoint Inhibitors in Patients with Metastatic Urothelial Carcinoma
ASCO 2025, bladder cancer, Metastatic Urothelial Carcinoma, FGFR3 alteration, Immune Checkpoint Inhibitors in Patients with Metastatic Urothelial Carcinoma, predictive markers for bladder cancer.
Novocure study shows improved pancreatic cancer survival
Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields (TTFields) therapy.
Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination
Nature Genetics – A pan-cancer analysis of genomic data from matched primary and metastatic tumors from 3,732 patients shows that increased genomic complexity and alterations…
Program Guide – ASCO Meeting Program Guide
Daneng Li City of Hope National Comprehensive Cancer Center, Duarte, CA Daneng Li, Sun Young Kim, Manish Patel, Hee Kyung Kim, Sunil Sharma, Sang Joon…
Program Guide – ASCO Meeting Program Guide
Tadana Vazquez Rothschuh Ponce Health Sciences University, Ponce, PR, Puerto Rico Tadana Vazquez Rothschuh, Keishla Arce-Ruiz, Steve Sutton, Avani Singh, Jenifer Ryan, Ashley Oates, B…
